Previous research has often focused on CD8+ cytotoxic T cells, however, CD4+ T cells have gained attention in the field, as they are not only essential to promote help to CD8+ T cells, but are also able to kill tumor cells. The gene discussed is CD8A; the disease is neoplasm.